Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)

China flag China · Delayed Price · Currency is CNY
5.83
+0.23 (4.11%)
At close: Aug 4, 2026
Market Cap3.67B -26.8%
Revenue (ttm)265.39M +9.9%
Net Income-228.67M
EPS-0.36
Shares Out 630.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,962,058
Open5.65
Previous Close5.60
Day's Range5.65 - 5.86
52-Week Range5.01 - 9.20
Beta0.45
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHA:688238

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China and internationally. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process de... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 715
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688238
Full Company Profile

Financial Performance

In 2025, SHA:688238's revenue was 267.70 million, an increase of 7.88% compared to the previous year's 248.15 million. Losses were -235.06 million, -26.96% less than in 2024.

Financial Statements